Thymosin Alpha-1
An immunomodulatory peptide studied for immune system support.
Overview
Thymosin Alpha-1 (Tα1) is a naturally occurring peptide produced by the thymus gland. It is a potent immunomodulator that influences T-cell maturation and function. It has been studied extensively for supporting immune responses, particularly in chronic infections and immunosuppressed states.
Dosing
Injection
- Starting dose
- 1.6 mg
- Common dose
- 1.6 mg
- Frequency
- 1–2× weekly
- Notes
- Approved Hep B dosing is 1.6 mg twice weekly (subQ).
Reported research/reference doses for educational purposes only. Always verify against primary literature and applicable regulations. Not medical advice.
How it works
Tα1 enhances the maturation and activity of T lymphocytes and natural killer (NK) cells, and modulates cytokine production. By "priming" the immune system, it helps mount a balanced innate and adaptive immune response.
Common research uses
- Immune system modulation
- Supporting T-cell and NK-cell function
- Chronic infection research
- Immune recovery after stress or illness
Considerations
Used as a prescription in some countries for Hepatitis B and C. Generally well tolerated with a good safety record, but should be used under medical guidance.